Fine, Kaplan and Black, R.P.C. Announces Claim Forms Now Being Accepted for Class Action Settlements If You Paid or Reimbursed for Certain Prescription Generic Drugs in the United States Between May 1, 2009 and December 31, 2019

The article states a federal court authorized class action settlements totaling $533 million for people who paid or reimbursed for certain U.S. prescription generic drugs between May 1, 2009 and Dec. 31, 2019. It is a legal notice with no disclosed company financials or guidance changes, implying limited near-term market impact.

Analysis

The article states a federal court authorized class action settlements totaling $533 million for people who paid or reimbursed for certain U.S. prescription generic drugs between May 1, 2009 and Dec. 31, 2019. It is a legal notice with no disclosed company financials or guidance changes, implying limited near-term market impact.